Learn more

ALPINE IMMUNE SCIENCES INC

Overview
  • Total Patents
    106
  • GoodIP Patent Rank
    13,477
  • Filing trend
    ⇧ 31.0%
About

ALPINE IMMUNE SCIENCES INC has a total of 106 patent applications. It increased the IP activity by 31.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are TYKOCINSKI MARK L, SEEHRA JASBIR and XBIOTECH INC.

Patent filings per year

Chart showing ALPINE IMMUNE SCIENCES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Swanson Ryan 89
#2 Kornacker Michael 73
#3 Kuijper Joseph L 29
#4 Maurer Mark F 27
#5 Demonte Daniel William 26
#6 Ardourel Dan 24
#7 Evans Lawrence 16
#8 Ryan Swanson 8
#9 Michael Kornacker 7
#10 Yang Jing 3

Latest patents

Publication Filing date Title
WO2020214867A1 Methods and uses of variant icos ligand (icosl) fusion proteins
WO2020113141A2 Cd86 variant immunomodulatory proteins and uses thereof
WO2020061376A2 Methods and uses of variant cd80 fusion proteins and related constructs
WO2019241758A1 Pd-1 variant immunomodulatory proteins and uses thereof
CA3087149A1 Multi-domain immunomodulatory proteins and methods of use thereof
US2020283500A1 Variant icos ligand immunomodulatory proteins and related compositions and methods
CN111801347A CTLA-4 variant immunomodulatory proteins and uses thereof
KR20190141146A PD-L2 variant immunomodulatory protein and uses thereof
AU2018236224A1 PD-L1 variant immunomodulatory proteins and uses thereof
EP3596114A2 Cd80 variant immunomodulatory proteins and uses thereof
CA3040296A1 Secretable variant immunomodulatory proteins and engineered cell therapy
WO2018022945A1 Cd112 variant immunomodulatory proteins and uses thereof
CN110088127A CD155 variant immune modulator and application thereof
KR20190005879A ICOS ligand mutant immunoregulatory proteins and uses thereof
KR20190006495A CD80 variant immunoregulatory proteins and uses thereof
CN108513576A Adjustable variant immunoglobulin superfamily structural domain and engineered cell therapy
US2019040014A1 Solid forms of an S-Nitrosoglutathione reductase inhibitor
CN107969128A Immune modulator with adjustable affinity